Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Scientific Reports|August 26, 2018
Impact of pore anisotropy on the thermal conductivity of porous Si nanowiresP Ferrando-Villalba, L D'Ortenzi, G G Dalkiranis, et al.
Scientific Reports|October 6, 2018
Author Correction: Impact of pore anisotropy on the thermal conductivity of porous Si nanowiresP Ferrando-Villalba, L D'Ortenzi, G G Dalkiranis, et al.
International Journal of Pharmaceutics|April 1, 2017
Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertensionVictor Segura-Ibarra, Javier Amione-Guerra, Ana S Cruz-Solbes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathwayElvin Blanco, Takafumi Sangai, Suhong Wu, et al.
Stem Cells Translational Medicine|February 20, 2020
GARP is a key molecule for mesenchymal stromal cell responses to TGF-β and fundamental to control mitochondrial ROS levelsAna Belén Carrillo-Gálvez, Sheyla Gálvez-Peisl, Juan Elías González-Correa, et al.
Pharmaceutics|March 26, 2022
Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast CancerAlba Navarro-Ocón, Jose L Blaya-Cánovas, Araceli López-Tejada, et al.
European Journal of Nutrition|November 22, 2018
Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathwaysMarina Cruz-Lozano, Adrián González-González, Juan A Marchal, et al.
International Journal of Biological Sciences|July 4, 2025
Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancerAraceli López-Tejada, Jose L Blaya-Cánovas, Francisca E Cara, et al.
International Journal of Biological Sciences|January 3, 2023
TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer ProgressionAraceli López-Tejada, Carmen Griñán-Lisón, Adrián González-González, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 22, 2024
Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cellsJesús Calahorra, José L Blaya-Cánovas, Olivia Castellini-Pérez, et al.
Pageof 3